Mader, Christopher

Discovering the anticancer potential of non-oncology drugs by systematic viability profiling

Corsello, S. M., Nagari, R. T., Spangler, R. D., Rossen, J., Kocak, M., Bryan, J. G., Humeidi, R., Peck, D., Wu, X., Tang, A. A., et al. (2020) · Nature Cancer

Computational Drug Discovery MethodsCancer Cells and Metastasis

Cited by 878

Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity

Kinker, G. S., Greenwald, A. C., Tal, R., Orlova, Z., Cuoco, M. S., McFarland, J. M., Warren, A., Rodman, C., Roth, J. A., Bender, S. A., et al. (2020) · Nature Genetics

Single-cell and spatial transcriptomicsCancer Genomics and Diagnostics

Cited by 445

Data Portal for the Library of Integrated Network-based cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data

Koleti, A., Terryn, R., Stathias, V., Chung, C., Cooper, D. J., Turner, J. P., Vidović, D., Forlin, M., Kelley, T. T., D’Urso, A., et al. (2018) · Nucleic Acids Research

Bioinformatics and Genomic NetworksResearch Data Management Practices

Cited by 193

A Computational Future for Preventing HIV in Minority Communities: How Advanced Technology Can Improve Implementation of Effective Programs

Brown, C. H., Mohr, D. C., Gallo, C. G., Mader, C., Palinkas, L., Wingood, G., Prado, G., Kellam, S. G., Pantin, H., Poduska, J., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes

HIV/AIDS Research and InterventionsMobile Health and mHealth Applications

Cited by 55

Cyber Security Issues and Challenges Related to Generative AI and ChatGPT

Pasupuleti, R., Vadapalli, R., & Mader, C. (2023) · 2023 Tenth International Conference on Social Networks Analysis, Management and Security (SNAMS)

Adversarial Robustness in Machine LearningInformation and Cyber Security

Cited by 26